hey penny how does that Motley Fool article taste.....INO top dog around here
Sanofi (NYSE:SNY) announced in February that it plans to develop a Zika virus vaccine. The French drugmaker already has vaccines on the market for Yellow Fever, Japanese Encephalitis, and Dengue. The company hopes that its Dengue vaccine could be leveraged quickly to also tackle Zika, because the two viruses belong to the same family. Unlike Inovio, though, Sanofi has not yet announced any pre-clinical testing results.
Another large pharmaceutical company could also be in the hunt. GlaxoSmithKline (NYSE:GSK) announced in January that it was evaluating whether its vaccine technology could be used to prevent infection by the Zika virus. Glaxo indicated that it planned to rapidly finish feasibility studies to determine if its vaccines might be effective for the Zika virus. However, the big drugmaker hasn't provided any updates since the January announcement.
The World Health Organization lists several other organizations working on Zika virus vaccines. Only two of them -- Inovio and Indian biotech Bharat -- had pre-clinical work in progress as of March. Bharat chairman Krishna Ella stated earlier this year that it would probably be 10 years before his company's Zika vaccine made it to market.
I am with wisker. 1) wisker is a knowledgeable long 2) wisker is sensible. Believe me wisker I am with you Patcarr is out of hand with his pie in the sky price targets and conspiracy theories. I am long and strong INO but enough f the overnight BS. Been in 3 years and will probably be two more years before I see the money I want.
c.chanley I do like that they got the HepC trial on someone else's dime; but you always want to raise capital when you are in a position of strength, which INO is right now. Yes, they could be even better in a few months, but it is a chance. This will tell me a lot from management if they don't do a secondary. It signals that they believe they have everything in line and expect an even better opportunity for raising capital in the future. Either way I am staying put too much potential in this company.
Are you joking look at my history of posts for INO on 2/11/2014, 3/22/2014, 3/30/2014 & 6/6/2015. Your calling me out because I don't post everyday. I only chime in when I think there is really something to say, and this is a concern. Let's wait until May 9th to see if I am right. For all of us shareholders I hope I am wrong.
Here is my worry. I have been holding for 3 years and now with the stock reaching 52 week highs and expected cash availability into 2018. There is no better time to raise cash for more runway than when you are in a strong stock price position and have plenty of money. This way they can extend cash runway until 2020. Earnings call is coming up on May 9th just the right time to announce 10 to 20 million share offering to place 100 to 200 million in the coffers. I would rather not see this happen. I would rather the company achieves some more targets with the cash they have, before asking for more.
Will this change my position? NOPE. I will take it for what it is and continue to hold because I see amazing things for this company. Let's see if I am right.